Welcome to ActoGeniX

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics™.

About ActoGeniX

ActoGeniX’s mission is to develop and commercialize innovative biological therapies, to improve the treatment and well-being of patients with gastrointestinal, immunological and metabolic diseases.


More about ActoGeniX →

About ActoBiotics™

ActoBiotics™ represent a novel concept for oral administration of therapeutic proteins, and are designed to be safer and more effective than injectable biopharmaceuticals. This novel class of biopharmaceuticals has the potential to treat a broad range of severe diseases.


More about ActoBiotics™ →

Video: What are ActoBiotics™?

Watch our introduction video on ActoBiotiocs by clicking on the image.


Recent Updates

Please click here for the latest news and headlines from ActoGeniX.

Show all news & events

The Biopharmaceutical Conference in Europe


11-13 June 2014
Barcelona, Spain



Microbiome/Microbiota R&D and Business Collaboration Forum – Presentation


28-29 April 2014
London Heathrow Marriott Hotel, London


BioEquity Europe 2014 – Presentation


21 – 22 May 2014
Hilton Amsterdam, the Netherlands